DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCorporate Action

Morepen Laboratories Limited — Appointment

NSE 3 hrs ago·4 Aug 2026, 8:50 am

Company NSE

Morepen Laboratories Limited has announced the re-appointment of Sushil Suri as its Chairman and Managing Director, effective October 20, 2026. This move extends his leadership role at the company for an additional term.

This development is significant for investors as it signals management's confidence in Suri's vision and strategy for the company's future growth. It provides continuity in leadership, which can be reassuring for stakeholders monitoring the company's long-term trajectory.

Investors should watch for any updates on the company's strategic roadmap under Suri's renewed leadership, as well as its execution of future business plans.